Clinical Trials Directory

Trials / Completed

CompletedNCT03519828

Oxidation-reduction Homeostasis in Cognitive Impairment Patients After Stroke

Effects of Oxidation-reduction Homeostasis on Cognitive Impairment in Patients With Ischemic Stroke

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Hui-Sheng Chen · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Cognitive impairment after ischemic stroke can affect not only the social adaptation ability, but also affect the comprehensive rehabilitation of patients. The damage of cognitive impairment after ischemic stroke is not lower than the body function defect after stroke. Many studies have shown that oxidative stress is one of the pathophysiological mechanisms of ischemic cerebrovascular disease. Many studies have reported that the oxidative-reduction of cells plays an important role in the life activities of organisms, affecting the health, aging and death of the organism. In the recent years, some scholars have suggested that post-stroke cognitive impairment may be related to oxidative-reduction homeostasis of the body, but the relevant evidence is lacking and needs to be further explored. Therefore, the purpose of this study is to explore the effect of oxidation-reduction homeostasis on cognitive impairment in patients with ischemic stroke, and provide a theoretical basis for the prevention and treatment of cognitive impairment after ischemic stroke.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention has been conductedIt is an observational study, and no intervention has been conducted

Timeline

Start date
2018-03-01
Primary completion
2018-12-30
Completion
2019-01-01
First posted
2018-05-09
Last updated
2019-07-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03519828. Inclusion in this directory is not an endorsement.